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Introduction: Cardiovascular (CV) morbidity and mortality are increased in patients with rheumatoid arthritis (RA).
Inflammation is thought to be an important factor in accelerated atherosclerosis in RA, whereas insulin resistance is
a known risk factor for atherosclerosis in RA. We hypothesised that adipokines could be a link between
inflammation, insulin resistance, and atherosclerosis in RA.
Methods: The common carotid artery (CCA) intima-media thickness (IMT), CCA resistive index (RI), and carotid plaques
were measured by ultrasonography in 192 patients with RA. Insulin resistance was assessed by the homeostasis model
assessment for insulin resistance (HOMA-IR). Serum adiponectin, leptin, resistin, tumor necrosis factor-α, and interleukin
(IL)-6 concentrations were determined.
Results: The CCA RI was associated with CCA IMT and the estimated total plaque volume after adjustment for
conventional CV risk factors. Among adipokines, resistin and IL-6 were correlated with inflammatory parameters. Leptin
and leptin:adiponectin (L:A) ratio were correlated with metabolic risk factors, including HOMA-IR. And L:A ratio was
related to the CCA RI after adjustment for conventional and nonconventional CV risk factors, including HOMA-IR,
erythrocyte sedimentation rate and C-reactive protein.
Conclusion: L:A ratio was associated with HOMA-IR and carotid RI. L:A ratio might be an independent factor for
predicting cardiovascular risk in patients with RA.Introduction
Cardiovascular (CV) morbidity and mortality are increased
in patients with rheumatoid arthritis (RA) [1-3]. However,
the pathogenesis of accelerated atherosclerosis in RA is not
completely understood, and cannot be explained solely by
conventional CV risk factors such as age, male sex, body
mass index (BMI), smoking, lipid profile, hypertension and
diabetes mellitus [2,4]. Inflammation is an important non-
conventional factor in the increased CV risk observed in
RA [5,6]. Insulin resistance, which is also important in the
development and progression of atherosclerotic CV disease
[7], has been suggested as a risk factor for atherosclerosis in
RA [8,9]. Insulin resistance is linked to obesity, especially
visceral fat accumulation, which alters adipokine secretion* Correspondence: yongbpark@yuhs.ac
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reproduction in any medium, provided the orprofiles, and is recognized as a state of adipose tissue dys-
function. On the other hand, insulin resistance contributes
to increased systemic inflammation by altering adipokine
secretion, which leads to activation of proinflammatory sig-
naling pathways [10,11]. Adipokines include adiponectin,
leptin, resistin, and some proinflammatory cytokines, such
as tumor necrosis factor alpha and interleukin (IL)-6. How-
ever, the relationship between adipokine concentrations, in-
flammation, insulin resistance, and atherosclerosis in
patients with RA has not been clearly defined.
The common carotid artery (CCA) intima-media thick-
ness (IMT) had been established as a valid marker of early
atherosclerosis [12]. Similarly, the carotid resistive index
(RI) correlates with the severity of atherosclerosis [13].
The IMT is a morphological parameter and represents the
histologically verified intima-media segment of the vascu-
lar wall. In contrast, the RI is a hemodynamic parameter
based on Doppler technology and relates to vascular re-
sistance [13]. Whereas the carotid IMT has beend. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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RI in these patients has not yet been studied.
We assessed the relationship between adipokines,
inflammation, insulin resistance and carotid atheroscler-
osis via CCA IMT, plaque and RI to test the hypothesis
that serum adipokines are a link between inflammation,
insulin resistance and atherosclerosis in patients with RA.
Methods
Study population
One hundred and ninety-two consecutive patients who
were diagnosed with RA at the rheumatology clinic in
Severance Hospital, Yonsei University Health System, Seoul,
Korea were recruited between September 2011 and
January 2012. All patients fulfilled the American College
of Rheumatology 1987 revised criteria for classifying RA
[15]. Patients with diabetes mellitus were excluded. The
study was approved by the Institutional Review Board
of Severance Hospital, and patients gave their written
informed consent.
Clinical assessments
Clinical characteristics were assessed on the same day
as the carotid ultrasound was performed. Clinical infor-
mation, including age, sex, and disease duration, history
of hypertension, medications, and smoking were assessed
by questionnaire. Medications for treatment of RA, in-
cluding biologics, were assessed by their prescription.
Height, body weight, waist circumference, and blood pres-
sure were measured. Tender and swollen joint counts
were counted by the same rheumatologist. Disease ac-
tivities of patients were assessed by the patients’ state-
ments of global well-being (via 100 mm visual analogue
scale) and the 28-joint disease activity (via the DAS28
ESR calculator using the erythrocyte sedimentation rate
(ESR)).
Laboratory assessments
Fasting serum insulin, glucose, high-density lipoprotein
(HDL) cholesterol, low-density lipoprotein cholesterol, tri-
glycerides (TG), ESR, and C-reactive protein (CRP) concen-
trations were determined in the hospital clinical laboratory.
The homeostatic model assessment for insulin resistance
(HOMA-IR) index was calculated. Serum concentrations of
adiponectin, leptin, resistin, tumor necrosis factor alpha,
and IL-6 were measured using the Lincoplex Milliplex im-
munoassay (Merck Millipore, Billerica, MA, USA).
Carotid ultrasound
Both carotid arteries were evaluated with high-resolution
ultrasonography (HD15; Philips, Bothwell, WA, USA)
with a L12-5 transducer. Three different longitudinal
views (anterior oblique, lateral, and posterior oblique) and
transverse views of both carotid arteries were obtained.For IMT measurements, far walls of both the right and
the left common carotid arteries 2 cm downstream from
the bifurcation were imaged at the lateral view. QLAB’s
IMT-quantification software measurement plug-in (Philips
Healthcare, DA Best, the Netherlands) was used to in-
crease the consistency and reliability of IMT measure-
ments. The presence of carotid plaque was investigated in
the internal carotid artery, the external carotid artery, the
bulb and the CCA. The plaque was identified as a discrete
projection of ≥50% from the adjacent wall into the vessel
lumen. The height and length of a plaque were measured
in the longitudinal view, and its width was measured in
the cross-sectional view. Plaque volume was estimated
automatically by the program plug-in after measuring each
length of the three-dimensional axis of the plaque. For RI
measurements, a pulsed wave-flow spectrum was recorded
and frozen from both middle/distal common carotid arter-
ies after 5 seconds of multiple identical waveforms. The RI
was calculated automatically according to the Pourcelot
formula as follows [16]:
RI = (peak systolic velocity – end-diastolic velocity)/
peak systolic velocity
A highly skilled single sonographer, blinded to the sub-
jects’ characteristics, performed all examinations
throughout the study.
Statistical analyses
Data were expressed as the median with interquartile
range for continuous variables. For categorical vari-
ables, counts and percentages were calculated. The
relationships between variables were determined by
Spearman’s correlation analysis because variables were
not normally distributed. Multiple linear regression
was used to analyze the RI and adjust the con-
founders: conventional CV risk factors included age,
sex, smoking, systolic blood pressure, BMI, waist cir-
cumference, glucose, TG, HDL cholesterol and low-
density lipoprotein cholesterol; and nonconventional
CV risk factors included inflammatory markers such
as ESR and CRP. Statistical significance was consid-
ered P <0.05. All statistical analyses were carried out
using SPSS software (version 19.0; SPSS Inc., Chicago,
IL, USA).
Results
Characteristics of patients with RA
One hundred and seventy-six patients (91.7%) were
women. The median age of patients was 55 years (45 to 62
years). Median disease duration was 9 years (4 to 15
years), median CRP was 1.7 mg/l (0.5 to 5.5 mg/l) and me-
dian DAS28 ESR was 3.1 (2.5 to 4.1), and most patients in
this study had low disease activities of RA. Median BMI
was 22.3 kg/m2 (20.2 to 24.6 kg/m2) and the median
HOMA-IR was 1.46 (0.96 to 2.27). Other demographic
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tional CV risk factors, concentrations of adipokines, ultra-
sonographic measurements and medications of 192 RA
patients are summarized in Table 1. The CCA RI, the
CCA IMT and concentrations of adipokines did not differ
between patients who received biologics and those who
did not.Table 1 Characteristics of patients with rheumatoid
arthritis (n = 192)
Age (years) 55 (45.3 to 62)
Women 176 (91.7)
Disease duration (years) 9 (4 to 15)
ESR (mm/hour) 35 (20 to 50)
CRP (mg/l) 1.7 (0.5 to 5.5)
DAS28 3.1 (2.5 to 4.1)
TNFα (pg/ml) 3.8 (2.7 to 5.3)
IL-6 (pg/ml) 2.3 (1.7 to 5.5)
Adiponectin (μg/ml) 192 (136.1 to 293.7)
Leptin (ng/ml) 7.7 (3.7 to 13.5)
L:A ratio × 105 3.64 (1.55 to 8.65)
Resistin (ng/ml) 4.7 (2.4 to 8.3)
Metabolic syndrome features
Metabolic syndrome 27 (14.1)
Waist circumference (cm) 77 (72 to 82.4)
Glucose (mg/dl) 86 (81 to 91)
Triglycerides (mg/dl) 94 (70 to 122)
HDL cholesterol (mg/l) 56 (47 to 65.8)
SBP (mmHg) 124 (114 to 134)
Hypertension 70 (36.5)
HOMA-IR 1.46 (0.96 to 2.27)
Nonmetabolic cardiovascular risk factors
BMI (kg/m2) 22.3 (20.2 to 24.6)
Total cholesterol (mg/dl) 184 (163 to 209.8)
LDL cholesterol (mg/dl) 107.2 (91.2 to 129.4)
Smoking history 19 (9.9)
Mean CCA RI 0.63 (0.60 to 0.66)
Mean CCA IMT (mm) 0.59 (0.51 to 0.68)
Total plaque number 2 (1 to 3)







Values are median (interquartile range) or n (%).BMI, body mass index; CCA, common carotid artery;
CRP, C-reactive protein; DAS28, Disease Activity Score
in 28 joints; ESR, erythrocyte sedimentation rate; HDL,
high-density lipoprotein; HOMA-IR, homeostatic model
assessment for insulin resistance; IL, interleukin; IMT,
intima-media thickness; L:A ratio, leptin:adiponectin ratio;
LDL, low-density lipoprotein; RA, rheumatoid arthritis;
RI, resistive index; SBP, systolic blood pressure; TNFα,
tumor necrosis factor alpha. aBiologics included etaner-
cept, adalimumab and infliximab.
Association of CCA resistance index with CCA intima-media
thickness, and plaque
Significant correlations between CCA RI and CCA IMT
and the plaque volume are shown in Table 2. The CCA
RI was associated with the mean CCA IMT (r = 0.193;
P = 0.007) and the maximum CCA IMT (r = 0.164;
P = 0.023). The RI was also associated with carotid plaque
volume (r= 0.167; P = 0.021). These correlations remained
significant after adjustment for conventional CV risk factors.
Association of adipokines with inflammation
Correlations between adipokines and parameters of in-
flammation are shown in Table 3. Resistin was associ-
ated with the ESR (r = 0.322; P <0.001), CRP (r = 0.209;
P = 0.004) and increased disease duration (r = 0.176;
P = 0.014). IL-6 was correlated with the ESR (r = 0.450;
P <0.001), CRP (r = 0.468; P <0.004) and DAS28 ESR
(r = 0.448; P <0.001). Adiponectin was positively corre-
lated with ESR (r = 0.162; P = 0.025). The associations
between resitin and ESR and between IL-6 and ESR and
CRP remained significant after adjustment for waist cir-
cumference and BMI. Tumor necrosis factor alpha was
positively correlated with leptin (r = 0.234; P = 0.001),
resistin (r = 0.142; P = 0.049) and leptin:adiponectin ra-
tio (L:A ratio) (r = 0.226; P = 0.002). Adiponectin had a
positive association with resistin (r = 0.213; P = 0.003).
Association of adipokines with metabolic risk factors
Correlations between adipokines and metabolic risk factors
are shown in Table 4. HOMA-IR, metabolic syndrome
criteria numbers, waist circumference, systolic blood pres-
sure, glucose, TG, and HDL cholesterol were included inTable 2 Correlation between CCA resistance index with
CCA intima-media thickness and plaque volume
r P value
Mean CCA intima-media thickness 0.193 0.007*
Maximum CCA intima-media thickness 0.164 0.023*
Total plaque volume 0.167 0.021*
CCA, common carotid artery. *P <0.05 after adjustment for conventional
cardiovascular risk factors including sex, body mass index, smoking, systolic
blood pressure, triglycerides, high-density lipoprotein cholesterol, and low-
density lipoprotein cholesterol.
Table 3 Coefficients of correlation between adipokines and parameters of inflammation
L:A ratio Adiponectin Leptin Resistin TNFα IL-6
ESR −0.074 0.162* −0.005 0.322*† 0.181* 0.450*†
C-reactive protein −0.041 0.137 0.026 0.209* 0.087 0.468*†
DAS28 ESR 0.021 0.068 0.054 0.095 0.074 0.448*
Disease duration −0.033 0.094 −0.008 0.176* 0.101 0.134
DAS28, Disease Activity Score in 28 joints; ESR, erythrocyte sedimentation rate; IL, interleukin; L:A ratio, leptin:adiponectin ratio; TNFα, tumor necrosis factor alpha.
*P <0.05. †P <0.05 after adjustment for adiposity including waist circumference and body mass index.
Kang et al. Arthritis Research & Therapy 2013, 15:R194 Page 4 of 7
http://arthritis-research.com/content/15/6/R194the metabolic risk factors. Leptin and the L:A ratio were
associated with multiple metabolic risk factors. Leptin
was associated with HOMA-IR (r = 0.369; P <0.001),
Metabolic syndrome criteria number (r = 0.388; P <0.001),
waist circumference (r= 0.488; P <0.001), and TG (r= 0.264;
P <0.001). The L:A ratio was correlated with HOMA-IR
(r = 0.377; P <0.001), Metabolic syndrome criteria num-
ber (r = 0.402; P <0.001), waist circumference (r = 0.431;
P <0.001), systolic blood pressure (r = 0.164; P = 0.023),
TG (r = 0.241; P = 0.001) and HDL cholesterol (r = −0.169;
P = 0.019). The L:A ratio showed a significant correlation
with HOMA-IR (Figure 1), and the correlation remained
significant after adjusting for conventional CV risk factors.Associations of common carotid resistance index with L:A
ratio after adjustment for conventional and
nonconventional cardiovascular risk factors
Age, waist circumference, BMI, HOMA-IR, and L:A ratio
were associated with increased CCA RI in the univariate
linear regression, as shown in Table 5. The L:A ratio was
significantly associated with CCA RI after adjustment for
age, waist circumference, BMI and HOMA-IR (β= 47.996 ±
22.723, r= 0.036) (data not shown). The L:A ratio remained
significantly associated with CCA RI after adjusting for
conventional CV risk factors, and for nonconventional
CV risk factors including HOMA-IR, ESR and CRP
(β = 49.558 ± 22.613; P = 0.030), as shown in Table 5.Table 4 Coefficients of correlation between adipokines and p
L:A ratio Adiponectin
HOMA-IR 0.377*† −0.113
MetSyn criteria number 0.402* −0.159*




HDL cholesterol −0.169* 0.261*
HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment for insulin
syndrome; SBP, systolic blood pressure; TNFα, tumor necrosis factor alpha. *P <0.05
age, sex, smoking, systolic blood pressure, waist circumference, glucose, triglycerideDiscussion
Our study showed a clear relationship between the L:A
ratio and CCA RI in patients with RA. We found that
CCA RI was correlated with CCA IMT and total plaque
volume in RA. Among adipokines, resistin and IL-6 were
correlated with inflammatory parameters. Leptin and the
L:A ratio were related to metabolic risk factors, including
HOMA-IR. The L:A ratio was associated with CCA RI in-
dependent of conventional CV risk factors and noncon-
ventional risk factors, including HOMA-IR, ESR and CRP.
The RI is a functional parameter that is easily determined
by Doppler sonography in contrast to IMT, a morpho-
logical parameter [16]. Before the appearance of morpho-
logical alterations that are detectable by the thickening of
the intima-media complex, the early form of arteriosclerosis
leads to endothelial dysfunction as an exclusively functional
disorder characterized by reduced elasticity and increased
peripheral resistance [17]. The RI may thus detect the
atherosclerotic process as early as observed by IMT. A
previous study revealed that the carotid RI predicted the
atherosclerosis score and CV mortality and morbidity
comparable with the IMT [17]. CV risk factors were
independently associated with the carotid RI and IMT
[18]. However, the carotid RI had not been previously
demonstrated in RA cohorts; this is the first study to
measure the carotid RI in RA patients, to our know-
ledge. In our study, CCA RI was associated with CCA IMT,
the estimated total plaque volume independent ofarameters related to insulin resistance
Leptin Resistin TNFα IL-6
0.369* 0.093 0.204* 0.076
0.388* 0.011 0.228* −0.016
0.488* −0.037 0.239* 0.045
0.119 0.033 0.112 −0.001
−0.076 −0.116 0.082 −0.102
0.264* 0.098 0.190* −0.073
−0.011 −0.002 −0.189* −0.025
resistance; IL, interleukin; L:A ratio, leptin:adiponectin ratio; MetSyn, metabolic
. †P <0.05 after adjustment for conventional cardiovascular risk factors including
s, HDL cholesterol, and low-density lipoprotein cholesterol.
Figure 1 Correlation of the leptin:adiponectin ratio and
homeostatic model assessment for insulin resistance. Log leptin:
adiponectin ratio (L:A ratio) showed highly significant correlation
with homeostatic model assessment for insulin resistance (HOMA-IR)
(r = 0.338; P <0.001), and the correlation remained significant after
adjusting conventional cardiovascular risk factors.
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as a marker (complementary to IMT) to signal early
atherosclerosis in RA. Further studies will be needed to
validate the value of the RI in RA patients.
Leptin and adiponectin are the most abundant adipo-
kines produced by adipocytes. These adipokines are
thought to provide an important link between obesity,
insulin resistance and related inflammatory disorders [11].
Leptin is known to have proinflammatory and proathero-
genic activities [19,20]. Leptin concentrations were inde-
pendently associated with coronary heart disease [21]
and predicted CV events in subjects with coronary
atherosclerosis [22]. In contrast to leptin, adiponectin
is a protein with insulin-sensitizing properties and anti-
inflammatory effect [23,24]. Clinical studies identified an
association between low serum concentration of adiponectinTable 5 Linear regression analysis for associations of CCA res
Variable Univariate linear regression analysis
β SE (β) P value
L:A ratio 66.661 22.157 0.003
HOMA-IR 0.008 0.003 0.012
Age 0.001 0.000 0.001
Waist circumference 0.002 0.000 0.000
BMI 0.004 0.001 0.003
BMI, body mass index; CCA, common carotid artery; HOMA-IR, homeostatic model a
error. aMultiple linear regression analysis for L:A ratio, conventional cardiovascular r
glucose, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cho
sedimentation rate and C-reactive protein) and L:A ratio.and CV events [25,26]. Resistin has proinflammatory prop-
erties in human [20]. Although studies in animal models
consistently show that resistin induces insulin resistance
[27], evidence for this effect in humans is less clear. We
showed that concentrations of adipokines were associ-
ated with systemic inflammation in this study. Resistin
and IL-6 were associated with inflammatory markers in-
cluding the ESR, CRP, DAS28 ESR (only with IL-6) and
disease duration (only with resistin). This was consistent
with previous reports of serum resistin and IL-6 being
related to systemic inflammation in RA [28-30]. Meanwhile,
leptin and adiponectin did not show any associations with
inflammatory parameters. This lack of association might
be because of relatively low inflammatory burdens of
subjects in this study. In addition, adiponectin was posi-
tively correlated with resistin. This finding might be due
to the compensatory mechanism of adiponectin in the
presence of inflammation in RA. Our results supported a
recent report that suggested a compensatory increase
of adiponectin receptors to counteract the excess in-
flammatory and atherogenic process in coronary artery
disease [31].
In the present study, leptin and the L:A ratio were re-
lated to metabolic risk factors and HOMA-IR, consistent
with findings that leptin resistance occurred and adipo-
nectin decreased in the insulin-resistant status [32]. Rho
and colleagues showed only leptin as being associated
with HOMA-IR in RA patients. However, the L:A ratio
was reported to be correlated with insulin resistance and
to possibly predict the risk of metabolic syndrome in the
nondiabetic population [33,34], which might be due to a
reciprocal response of leptin and adiponectin to increasing
adiposity. Consistent with this, we confirmed an associ-
ation between the L:A ratio and metabolic risk factors,
especially HOMA-IR in patients with RA.
Additionally, the L:A ratio was related to carotid IMT,
and was an independent factor for predicting CV disease
in healthy population [35]. Meanwhile, only resistin and
IL-6 were related to endothelial activation in RA [36,37],istance index with dependent variables
Multivariate linear regression analysisa
β SE (β) P value Final model (R2)





ssessment for insulin resistance; L:A ratio, leptin:adiponectin ratio; SE, standard
isk factors (age, sex, smoking, systolic blood pressure, waist circumference, BMI,
lesterol, HOMA-IR), and nonconventional cardiovascular risk factors (erythrocyte
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carotid IMT in patients with RA [38]. We therefore
investigated the association between the L:A ratio and
carotid atherosclerosis in patients with RA, and revealed
that the L:A ratio was independently correlated with the
CCA RI, after adjusting for conventional risk factors
and nonconventional risk factors, including HOMA-IR.
The L:A ratio might be an independent factor for the
prediction of CV risk in RA. There are few reports avail-
able on the L:A ratio and CV risk in other inflammatory
diseases. In patients who were on peritoneal dialysis for
end-stage renal disease, the L:A ratio has been reported
as being related to mortality secondary to chronic
inflammation [39]. The L:A ratio being independently
related to CV risk in RA is a novel finding.
Little is known about the relationship between adipo-
kines, insulin resistance, and atherosclerosis in patients
with RA. Circulating proinflammatory cytokines that
secreted from inflamed joints may alter the function of
distant tissues (for example, adipose, skeletal muscle,
liver, and vascular endothelium) to generate a spectrum
of proatherogenic changes that include insulin resistance,
prothrombotic effects and endothelial dysfunction [40].
We focused on insulin resistance, one of the pathways
that contribute to atherosclerosis in RA, and had hy-
pothesized that adipokines link inflammation, insulin
resistance, and carotid atherosclerosis. Insulin resistance
maintains some degree of inflammation, and RA itself
exhibits persistent inflammation, and both insulin re-
sistance and RA continue to affect CV risk, thus mutu-
ally reinforcing each other [41]. This reinforcement
could be one mechanism underlying the pathogenesis
of accelerated atherosclerosis in RA, and our results
support this hypothesis.
Conclusions
We investigated the overall relationship between adipo-
kines, inflammation, insulin resistance, and the carotid
RI in patients with RA. The L:A ratio was significantly
associated with HOMA-IR and with carotid RI. Finally,
the L:A ratio might be an independent factor for the
prediction of CV risk in RA.
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